Paolo Avalle,
Senior Research Chemist,
Merck
After a PhD in SSNMR at the University of Durham, followed by a post –doctoral research project, Paolo Avalle joined Merck Sharp & Dohme UK.
As preformulation analyst he gained significant experience in API stability, phase selection and polymorphism but also on API-excipient compatibility and drug product stability. By using and developing novel analytical approached based on NIR, Raman and MRI imaging, Paolo supported the formulation development process of controlled release formulations, bridging traditional dissolution experiment with a more in depth mechanistic understanding of the drug release phenomena.
|
|
|